Short answer (as of July 2026): NYC’s professional AI story is workflow copilots sold into law, finance, clinical, and meeting-heavy operators — not foundation models. The companies to know are Granola ($125M Series C, Mar 2026, $1.5B; London HQ), Harvey (legal; SF HQ, deep NYC AmLaw demand), AlphaSense ($350M at $7.5B, Jun 2026; NYC), Hebbia ($130M Series B; NYC document reasoning), Avo ($10M Series A, 2026; NYC clinical), and Zenskar ($15M Series A; NYC agentic billing). Treat HQ honestly: many “NYC AI copilots” are bought in NYC even when built elsewhere.

Copilots vs agents vs document AI

Products migrate: Granola started as a meeting notepad and is shipping APIs/MCP so other agents can use meeting context — still a professional copilot at the UI, with agent infrastructure underneath. Hebbia is often sold as knowledge-worker AI but is primarily document reasoning (a natural bridge to a document-AI map).

Workflow map (Startup · Professional workflow · Vertical · Funding signal · Investors)

Scope note: This is a buyer-and-builder map for professionals in NYC, not a pure HQ census. We exclude horizontal ChatGPT wrappers and foundation labs.

Meetings: Granola and the notepad → context stack

Granola’s bet is that professionals will not tolerate meeting bots, but will pay for local transcription + structured notes + enterprise context. The Mar 2026 round (Index / Kleiner) priced that shift at $1.5B. Competitors (Otter, Fireflies, Zoom AI Companion, Microsoft Copilot) commoditize raw notes; Granola’s differentiation is privacy posture + APIs/MCP so meeting memory feeds other tools. For founders selling into NYC operators, the lesson is measurable: time-to-usable notes and governance, not “AI meeting magic.” Full deal write-up: Granola’s $125M.

Legal: Harvey (SF) + NYC AmLaw demand

Harvey is the category flagship for AI copilots for professionals in law — research, drafting, and document analysis with high willingness to pay. HQ is San Francisco; the reason it belongs on an NYC map is buyer density: 50+ AmLaw 100 offices, corporate GCs, SDNY/EDNY litigation, and NYDFS/SEC adjacency. NYC-native legal AI names (Spellbook, Eve, Garvanza, Avanta, and capital-markets specialists like Nolan) are earlier or thinner on disclosed rounds — treat them as watchlist, not funded peers of Harvey. Deeper legal context: NYC legal tech 2026 and Harvey / a16z.

Finance: AlphaSense copilots vs Hebbia document AI

• AlphaSense (NYC) is the scaled market-intelligence copilot: sourced answers over filings, transcripts, and research for analysts and strategy teams. The June 2026 $350M / $7.5B mark is a signal that enterprises pay for citations + workflow, not chat novelty.
• Hebbia (NYC) owns multi-document reasoning for banking and professional services — closer to document AI than a chat sidebar. Include it when scouting “AI for knowledge workers,” but do not blur it into meeting copilots.

Zenskar sits on the agent side of finance (billing execution). Pair it with the agents map when diligence requires autonomous revenue workflows.

Clinical: Avo’s EHR-native copilots

Avo (NYC) raised $10M Series A (Noro-Moseley lead; AlleyCorp and health-focused angels/VCs) to put copilots inside Epic / athena / MEDITECH workflows — chart assist, documentation, evidence routing — with partnerships aimed at reducing hallucination risk (e.g. DynaMed / EBSCO). That is the clinical definition of an AI copilot for professionals: point-of-care, governed, EHR-embedded. Deal notes: Avo $10M Series A.

Who funds this category in NYC

Specialists that repeatedly show up around applied enterprise AI (copilots and agents):

• Work-Bench — enterprise / infra angle
• Primary Venture Partners — NYC-focused early
• Insight Partners — growth software
• Thrive Capital, Union Square Ventures, Lerer Hippeau — adjacent NYC AI/software

Global names (Sequoia, a16z, Index, Kleiner, Bessemer) still lead many of the largest rounds; link only where we have fund pages.

Founder / investor take

1. Pitch the workflow, not the model — lawyers, clinicians, and analysts buy time saved inside systems of record.
2. Label your product honestly — copilot vs agent vs document AI changes buyer, security review, and competitive set.
3. NYC advantage is distribution — AmLaw, banks, PE, and health systems are walking-distance buyers; HQ can be elsewhere if GTM is here.
4. Cross-read — autonomous stack: NYC AI agents 2026 map; meeting infrastructure: Granola $125M.

Known gaps

• Several promising NYC legal AI names lack clean, recent round disclosures suitable for ranking.
• “AI copilots for professionals” queries sometimes intend Microsoft Copilot / Google Duet — those are incumbent suites, not startups; we do not treat them as peers here.
• Document-AI cluster depth (beyond Hebbia/Granola adjacency) belongs in a dedicated document startups piece.

Sources

1. Granola Series C (TechCrunch, Mar 25, 2026): https://techcrunch.com/2026/03/25/granola-raises-125m-hits-1-5b-valuation-as-it-expands-from-meeting-notetaker-to-enterprise-ai-app/
2. Granola Series C (company): https://www.granola.ai/blog/series-c
3. Harvey Series D (company blog): https://www.harvey.ai/blog/harvey-raises-series-d
4. AlphaSense $350M (Crunchbase News, Jun 2026): https://news.crunchbase.com/venture/biggest-funding-rounds-june-5-2026/
5. Hebbia Series B (TechCrunch, Jul 2024): https://techcrunch.com/2024/07/09/ai-startup-hebbia-rased-130m-at-a-700m-valuation-on-13-million-of-profitable-revenue/
6. Avo $10M Series A (company, Mar 31, 2026): https://www.avomd.com/resources/avo-raises-10-million-series-a-to-be-the-clinical-ai-platform-powered-by-trusted-knowledge
7. Zenskar $15M Series A (BusinessWire, Apr 2026): https://www.businesswire.com/news/home/20260416872552/en/Zenskar-Raises-%2415-Million-Series-A-to-Expand-Agentic-Capabilities-for-B2B-Revenue-Automation
8. Related VCT maps: /nyc-ai-agents-startup-scene-2026-map, /2026-granola-125m-enterprise-ai